Trial Profile
Pharmacokinetics and pharmacodynamics of insulin detemir (Levemir) and insulin glargine (Lantus) after subcutaneous injection of increasing doses into morbidly obese type 2 diabetic subjects
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 04 Nov 2006
Price :
$35
*
At a glance
- Drugs Insulin detemir (Primary) ; Insulin glargine (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms INSULIN-KINETICS
- 04 Nov 2006 New trial record.